Adjuvant Nivolumab Therapy for MIBC: Safety and Efficacy Data from CheckMate 274

Video

Dr Terence Friedlander explains safety and efficacy data from the CheckMate 247 trial, which led to the FDA approval of adjuvant nivolumab for patients with MIBC.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content